Carbohydrate Deficient Transferrin for Alcohol Use

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> PRODUCTS

Carbohydrate Deficient Transferrin for Alcohol Use

Products	Carbohydrate Deficient Transferrin for Alcohol Use
Company	ARUP Laboratories
Item	Carbohydrate Deficient Transferrin for Alcohol Use
Features
Description	ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info	ARUP Laboratories Customer Service: (800) 522-2787 Web site: http://www.aruplab.com

Related medicine products :

1. Carbohydrate Deficient Transferrin for Congenital Glycosylation Disorders
2. Transferrin (Liquid)
3. Transferrin
4. Beta-2 Transferrin
5. Glycosylated Transferrin
6. Soluble Transferrin Receptor
7. Transferrin Receptor Level
8. Transferrin, Beta-2
9. Transferrin Saturation %
10. Transferrin, Serum
11. Alcoholic Giemsa Stain

TAG: Carbohydrate Deficient Transferrin for Alcohol Use

Medicine Products:

Yankauer suction tube - chrome plated Frazier suction tubes Yankauer Redmond frazier suction tubes - semi-rigid with slot

Breaking Medicine News(10 mins):Health News:More 20 mph zones in London would prevent 100 killed or seriously injured casualties each year 2 Health News:Novel detection method unmasks circulating breast cancer cells 2 Health News:Novel detection method unmasks circulating breast cancer cells 3 Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 2 Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 3 Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 4 Health News:Autism Research at the Children's Hospital of Philadelphia Is Among Time Magazine's Top 10 Medical Breakthroughs 2

[0] More 20 mph zones in London would prevent 100 killed or seriously injured casualties each year [0] Novel detection method unmasks circulating breast cancer cells [0] Many Stroke Survivors Don't Take Lifesaving Meds [0] Effort to Regenerate Injured Spinal Cords Turns to a New Model [0] Autism Research at the Children's Hospital of Philadelphia Is Among Time Magazine's Top 10 Medical Breakthroughs

Other Medicine News:Health News:University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix 2 Health News:University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix 3 Health News:Cleveland Clinic Press Releases Journal-Writing Book 'Write for Life: Healing Body, Mind, and Spirit Through Journal Writing' by Sheppard B. Kominars, Ph.D. 2 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 2 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 3 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 4 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 5 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 6 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 7 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 8 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 9 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 10 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 11 Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 12 Health News:Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs 2 Health News:Counseling Boosts Alzheimer's Caregivers' Health 2

Hospitals Agree to Pay Fees in Exchange for More Income, but Consumers in the Dark About What They'll be Charged Under Nunez Plan University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix Cleveland Clinic Press Releases Journal-Writing Book 'Write for Life: Healing Body, Mind, and Spirit Through Journal Writing' by Sheppard B. Kominars, Ph.D.Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs Counseling Boosts Alzheimer's Caregivers' Health

Breaking Medicine Technology:New Executive Leadership and CEO Announced for BiPar Sciences 2 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4 ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2 ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3 ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4 New artificial enzyme safer for nature 10482 1 New artificial enzyme safer for nature 10482 2 Now hear this 10478 1 Oct 26 public symposium on life sciences 10475 1

[0] New Executive Leadership and CEO Announced for BiPar Sciences [0] Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy [0] ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)